The revenue stands at ₹575.12 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.35 per cent from ₹521.17 crore. This corresponds to a year-on-year *(YoY) decline of 2.05 per cent.
Operating Profit stands at ₹35.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.13 per cent from ₹44.78 crore. This corresponds to a year-on-year *(YoY) decline of 57.80 per cent.
PBDT stands at ₹49.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 84.79 per cent from ₹324.68 crore. This corresponds to a year-on-year *(YoY) decline of 43.54 per cent.
Profit Before Tax stands at ₹18.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 93.60 per cent from ₹293.43 crore. This corresponds to a year-on-year *(YoY) decline of 67.49 per cent.
Net Profit stands at ₹10.91 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 95.87 per cent from ₹264.29 crore. This represents a 79.40 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | 5.08% | 29.27% | 27.30% | 43.30% | -0.58% | -24.05% |
| Gufic BioScience | -4.24% | -6.99% | 21.61% | 21.82% | 1.33% | -5.89% |
| Aarti Drugs | -1.32% | 0.41% | 0.03% | 5.55% | -6.47% | -20.88% |
| Novartis India | 0.33% | -1.85% | 7.01% | 40.04% | 68.13% | 31.91% |
| Panacea Biotec | -3.77% | -4.74% | 34.87% | 61.53% | 47.47% | 16.64% |
| Solara Active | 0.61% | 10.03% | 14.84% | 31.10% | -2.25% | 14.35% |
| Dishman Carbogen | -3.19% | -4.40% | -0.06% | 11.75% | -21.73% | -37.02% |
Non-Executive & Non-Independent Director : Pranay Godha
Managing Director & Chief Executive Officer : Pabitra Bhattacharya
Company Sec. & Compli. Officer : Pradeep Bhandari
Chairman (Non-Executive) : Prakash A Mody
Independent Director : Anand T Kusre
Independent Director : Arun Todarwal
Independent Director : Swati Patankar